Viewing Study NCT06875193


Ignite Creation Date: 2025-12-25 @ 1:15 AM
Ignite Modification Date: 2026-01-01 @ 5:38 AM
Study NCT ID: NCT06875193
Status: RECRUITING
Last Update Posted: 2025-03-17
First Post: 2025-02-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes
Sponsor: Dong Wha Pharmaceutical Co. Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: DW6012-IV-2
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators